Table: begin end state 1 29 cytoplasmic 30 48 transmembrane 49 58 non-cytoplasmic 59 81 transmembrane 82 88 cytoplasmic 89 108 transmembrane 109 113 non-cytoplasmic 114 137 transmembrane 138 157 cytoplasmic 158 178 transmembrane 179 189 non-cytoplasmic 190 210 transmembrane 211 230 cytoplasmic 231 253 transmembrane 254 259 non-cytoplasmic 260 280 transmembrane 281 286 cytoplasmic 287 306 transmembrane 307 325 non-cytoplasmic 326 344 transmembrane 345 352 cytoplasmic 353 372 transmembrane 373 377 non-cytoplasmic 378 402 transmembrane 403 412 cytoplasmic 413 435 transmembrane 436 446 non-cytoplasmic 447 465 transmembrane 466 477 cytoplasmic
Input: >CCNA_01071 MTATTEATRLTPVARARAILGGSAGNLVEWYDWFAYAAFTLYFAPAFFPKGDQTVQLLQA AAVFFLGFVARPIGAWIMGLYADHAGRRAALSVSVSLMCAGAFIIAITPDFQTIGLWAPA ILLFARVLQGLSVGGEYGASATYMSEMAGKARRGFWSSFHYVTLIAGQLLALGVLIILQR TLGEEALKEWAWRVPFIIGALLAVVVFWIRRGLEESVSFKRPAQSETLSRGQIISAGAFL SLTIASGVVGLMGGPLAKAGQYLGAAFLVLFFVSLIVPLIRRHPRESLLIMGLTAGGSLT FYVYTTYMQKFLVNTAGFSKAQASEISALSLIAFMLMQPLAGWLSDRFGRKPMLIIAFGG GVLTIWPIMTAISQTNSVGVALALILVGVAFQSCYTAISAVVKAEMFPAEIRALGVALPY ALANVLFGGTAEMVALAFKHENLESTFYVYVAAVMTIGLICSIILKDTGRHSLIHED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server